AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2016
Mar 24, 2016
33431_dirs_2016-03-24_d62f88df-2329-4147-83e0-99129623e07e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-03-21
Reporting Person: SKINNER GREGORY S (VP Finance and Admin & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-21 | Common Stock | M | 22500 | $6.22 | Acquired | 256443 | Direct |
| 2016-03-21 | Common Stock | M | 12815 | $10.92 | Disposed | 243628 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-21 | Incentive Stock Option (right to buy) | $10.92 | X | 22500 | Disposed | 2016-05-21 | Common Stock (22500) | Direct |
Footnotes
F1: Mr Skinner surrendered to the Issuer the right to receive an aggregate of 12,815 shares of Common Stock. Mr. Skinner did not sell any shares of Common Stock in connection with the foregoing exercise.
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1